RECITALSTrials Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research • Maryland
CLINICAL TRIALS AGREEMENTTrials Agreement • January 28th, 2022 • Indiana
THIS CLINICAL TRIALS AGREEMENT (hereinafter referred to as the “Agreement”), effective as of (hereinafter referred to as the “Effective Date”) is by and between , a corporation organized under the laws of the State of whose offices are located at , (hereinafter referred to as “Sponsor”); and the Trustees of Indiana University, an educational institution organized under the laws of the State of Indiana, whose address is Indiana University, Attn: Clinical Trials Office, 410 West 10th Street, 1020, Indianapolis, IN 46202 (hereinafter referred to as “Institution”). Sponsor and Institution may be referred to individually as “Party” or collectively as “Parties”.
South Carolina Clinical Trials Agreement (Agreement) Agreement to Reduce Cancer Morbidity & Mortality in South CarolinaTrials Agreement • August 25th, 2020 • South Carolina
Purpose of this Agreement The intent and purpose of this Agreement is to provide for insurance coverage for certain services related to cancer for those South Carolinians covered by the health benefit plans issued by the undersigned health insurers, health maintenance organizations, and self-insured governmental employers. The general area covered pursuant to the is Agreement is coverage of the routine patient care costs for persons participating in cancer clinical trials within South Carolina 1.0 Cancer Clinical Trials 1.0.1 Cancer Clinical Trials Covered Pursuant to this Agreement The parties to this Agreement agree that for all those insured, diagnosed with cancer, and accepted into a Phase II, Phase III, or Phase IV clinical trial for cancer, group health plan contracts, as defined in the Employee Retirement Income and Security Act of 1974, and self-insured governmental employers coverage issued by the undersigned that provide for hospital, medical, or surgical coverage i
2 REDACTED COPYTrials Agreement • January 11th, 1996 • Nu Tech Bio Med Inc • Services-medical laboratories
Florida Clinical Trials AgreementTrials Agreement • November 8th, 2013
The undersigned parties to this Florida Clinical Trials Agreement (Agreement) acknowledge that Florida ranks higher than the national average in the incidence and mortality of cancer. The undersigned parties to this Agreement acknowledge that cancer is a leading cause of death in Florida. The parties further acknowledge that many cancers can be treated successfully if detected early. The undersigned health insurers, health maintenance organizations, and self-insured governmental employers have a compelling interest in improving the methods of cancer detection, treatment, and prevention.
INTRODUCTIONTrials Agreement • March 28th, 2003 • Vion Pharmaceuticals Inc • Biological products, (no disgnostic substances) • District of Columbia
